14 May 2022>: Clinical Research
Case-Control Study to Investigate the Association Between Serum Apolipoprotein B/A1 Ratio and Atrial Fibrillation by Sex in 920 Patients from China
Xia Zhong 1ACE , Huachen Jiao 2DFG* , Dongsheng Zhao 1BC , Jing Teng 1AF , Mengqi Yang 1BEDOI: 10.12659/MSM.936425
Med Sci Monit 2022; 28:e936425
Table 3 Differences of serum APOB/APOA1 ratio in male and female patients with atrial fibrillation.
Variable | n | APOB/APOA1 ratio | P value |
---|---|---|---|
Paroxysmal AF | |||
Men | 174 | 0.83±0.74 | 0.099 |
Women | 146 | 0.73±0.27 | |
Permanent AF | |||
Men | 186 | 0.73±0.27 | 0.455 |
Women | 314 | 0.71±0.30 | |
AF+hypertension | |||
Men | 293 | 0.77±0.62 | 0.208 |
Women | 345 | 0.72±0.30 | |
AF+CHD | |||
Men | 393 | 0.77±0.54 | 0.107 |
Women | 419 | 0.72±0.30 | |
AF+diabetes | |||
Men | 138 | 0.84±0.83 | 0.159 |
Women | 136 | 0.73±0.38 | |
AF patients using statins | |||
Men | 304 | 0.76±0.59 | 0.110 |
Women | 301 | 0.70±0.28 | |
AF patients non-using statins | |||
Men | 156 | 0.76±0.28 | 0.368 |
Women | 159 | 0.73±0.31 | |
Data are presented as mean±SD. AF – atrial fibrillation; APOA1 – apolipoprotein A1; APOB – apolipoprotein B; CHD – coronary heart disease. |